The market for hormones in dosage form, excluding contraceptives and antibiotics, in Kenya has exhibited fluctuations between 2013 and 2023. The market value stood at 71.144 million USD in 2023. Initially, the market experienced a steady growth trend from 2013 to 2017, followed by slight fluctuations from 2018 to 2023. Notably, 2020 and 2021 saw significant year-on-year increases of 5.72% and 5.46% respectively, before the market contracted by 8.5% in 2022 and slightly recovered with a 0.64% increase in 2023.
Factors to watch for future trends include:
- Advancements in medical technology enhancing hormone treatment efficiency.
- Regulatory changes impacting market dynamics.
- Shifts in healthcare demand influenced by demographic changes in Kenya.
- Economic conditions affecting healthcare spending.
